Matches in Wikidata for { <http://www.wikidata.org/entity/Q79405039> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q79405039 description "artículu científicu espublizáu n'avientu de 2006" @default.
- Q79405039 description "scientific article published on 01 December 2006" @default.
- Q79405039 description "wetenschappelijk artikel" @default.
- Q79405039 description "наукова стаття, опублікована в грудні 2006" @default.
- Q79405039 name "Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H)" @default.
- Q79405039 name "Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H)" @default.
- Q79405039 type Item @default.
- Q79405039 label "Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H)" @default.
- Q79405039 label "Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H)" @default.
- Q79405039 prefLabel "Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H)" @default.
- Q79405039 prefLabel "Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H)" @default.
- Q79405039 P1433 Q79405039-B68EE105-8F31-4B2E-A70B-BA7F43196AC3 @default.
- Q79405039 P1476 Q79405039-A70D42CD-954A-496B-9477-BD34D8FDB646 @default.
- Q79405039 P2093 Q79405039-78D2A6B3-4AE8-4023-A4BA-873967AA2925 @default.
- Q79405039 P2093 Q79405039-99373519-B429-4767-B37D-F0DF7675A369 @default.
- Q79405039 P2093 Q79405039-D16BC9AF-4FFC-4255-9EEE-B5A5549C9CB6 @default.
- Q79405039 P2093 Q79405039-D36188C4-FD09-4A93-B717-69436FC3B712 @default.
- Q79405039 P2093 Q79405039-ED4C3BAB-61B9-4B1B-B29A-55C6E616780A @default.
- Q79405039 P304 Q79405039-5BC594F9-1384-4517-91D7-8264DE612FCD @default.
- Q79405039 P31 Q79405039-7260C48F-DAAD-4DC6-BD28-7C1AB8E5FC1B @default.
- Q79405039 P356 Q79405039-E76C95D3-9D18-4F83-9C48-996A88C23A8B @default.
- Q79405039 P407 Q79405039-F44F7213-E3EF-42F5-93FB-726AE7CA45AF @default.
- Q79405039 P433 Q79405039-617338CC-5E73-40A5-AA71-E8D8F5694C6D @default.
- Q79405039 P478 Q79405039-D0464D64-8E56-4218-B1CB-9A27F7B5F278 @default.
- Q79405039 P50 Q79405039-11ed86ec-4c66-7492-e312-7d201fe2217b @default.
- Q79405039 P50 Q79405039-7ef8474f-4e0a-06d7-48f6-5c38977eabc2 @default.
- Q79405039 P50 Q79405039-989efe41-456b-c6dd-b767-3ecad04c44d5 @default.
- Q79405039 P577 Q79405039-BAF3FF25-D348-4149-8F85-A735F868B62F @default.
- Q79405039 P698 Q79405039-0238FD56-7696-496C-BA51-1458B7BAAD5D @default.
- Q79405039 P356 1078-0432.CCR-06-1275 @default.
- Q79405039 P698 17145843 @default.
- Q79405039 P1433 Q332253 @default.
- Q79405039 P1476 "Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H)" @default.
- Q79405039 P2093 "Henry Y Dong" @default.
- Q79405039 P2093 "Jeffery L Kutok" @default.
- Q79405039 P2093 "Jeremy S Abramson" @default.
- Q79405039 P2093 "Scott J Rodig" @default.
- Q79405039 P2093 "Steven P Treon" @default.
- Q79405039 P304 "7174-7179" @default.
- Q79405039 P31 Q13442814 @default.
- Q79405039 P356 "10.1158/1078-0432.CCR-06-1275" @default.
- Q79405039 P407 Q1860 @default.
- Q79405039 P433 "23" @default.
- Q79405039 P478 "12" @default.
- Q79405039 P50 Q110078288 @default.
- Q79405039 P50 Q89030667 @default.
- Q79405039 P50 Q90028058 @default.
- Q79405039 P577 "2006-12-01T00:00:00Z" @default.
- Q79405039 P698 "17145843" @default.